Active Ingredient History

  • Now
Estazolam, a triazolobenzodiazepine derivative, is an oral hypnotic agent with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam. Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. Used for the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. Marketed under the brand names ProSom, Eurodin.   NCATS

  • Mol. Mass: 294.738
  • ALogP: 3.27
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$2.5302 - $2.8415
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

8-chloro-6-phenyl-4h-s-triazolo(4,3-a)(1,4)benzodiazepine | abbott-47631 | estazolam | estazolamum | eurodin | prosom | tasedan


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue